Shares of Biodexa Pharmaceuticals Plc (BDRX) are climbing about 69 percent on Thursday morning trading after it announced a partnership with Syngene International Ltd for the manufacture of both MTX240 active pharmaceutical ingredient and dosage form.
The company's shares are currently trading at $1.05 on the Nasdaq, up 69.49 percent. The stock opened at $0.9235 and has climbed as high as $1.35 so far in today's session. Over the past year, it has traded in a range of $0.6010 to $19.300.
Moreover, the company is planning to file an IND and initiate a Phase 1b/2a study towards the end of the year.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.